{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:04:58Z","timestamp":1790744698025,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370350"],"award-info":[{"award-number":["82370350"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170353"],"award-info":[{"award-number":["82170353"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejphar.2026.178561","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:24:11Z","timestamp":1768609451000},"page":"178561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Vericiguat inhibits the progress of cardiac hypertrophy and prevents hypertrophy-induced heart failure by multiple mechanisms"],"prefix":"10.1016","volume":"1015","author":[{"given":"Ying-Qi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6497-876X","authenticated-orcid":false,"given":"Guo-Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178561_bib1","first-page":"8611","article-title":"Angiotensin receptor-neprilysin inhibitor attenuates ischemia-hypoxia-induced myocardial injury via inhibition of autophagy","volume":"14","author":"An","year":"2022","journal-title":"American journal of translational research"},{"key":"10.1016\/j.ejphar.2026.178561_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pharep.2017.07.014","article-title":"Curcumin inhibits cardiac hypertrophy and improves cardiovascular function via enhanced Na(+)\/Ca(2+) exchanger expression after transverse abdominal aortic constriction in rats","volume":"70","author":"Bai","year":"2018","journal-title":"Pharmacol. Rep. : PR"},{"key":"10.1016\/j.ejphar.2026.178561_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41392-024-02019-4","article-title":"EphrinB2-mediated CDK5\/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation","volume":"9","author":"Bai","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.178561_bib4","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1038\/s41467-023-39516-z","article-title":"Subcellular second messenger networks drive distinct repellent-induced axon behaviors","volume":"14","author":"Baudet","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178561_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cells12131780","article-title":"The microenvironment of the pathogenesis of cardiac hypertrophy","volume":"12","author":"Bazgir","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.178561_bib6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/CIRCULATIONAHA.123.067592","article-title":"Inhibition of Hmbox1 promotes cardiomyocyte survival and glucose metabolism through gck activation in Ischemia\/Reperfusion Injury","volume":"150","author":"Bei","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178561_bib7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.21037\/atm-22-2583","article-title":"Soluble guanylate cyclase (sGC) stimulator vericiguat alleviates myocardial ischemia-reperfusion injury by improving microcirculation","volume":"10","author":"Cai","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.178561_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125151","article-title":"Lysine crotonylation of SERCA2a correlates to cardiac dysfunction and arrhythmia in Sirt1 cardiac-specific knockout mice","volume":"242","author":"Chen","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejphar.2026.178561_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.peptides.2017.02.008","article-title":"Exendin-4 inhibits structural remodeling and improves Ca(2+) homeostasis in rats with heart failure via the GLP-1 receptor through the eNOS\/cGMP\/PKG pathway","volume":"90","author":"Chen","year":"2017","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2026.178561_bib10","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/jch.14047","article-title":"Comparative efficacy of different types of antihypertensive drugs in reversing left ventricular hypertrophy as determined with echocardiography in hypertensive patients: a network meta-analysis of randomized controlled trials","volume":"22","author":"Chen","year":"2020","journal-title":"Journal of clinical hypertension (Greenwich, Conn.)"},{"key":"10.1016\/j.ejphar.2026.178561_bib11","article-title":"Empagliflozin mitigates cardiac hypertrophy through cardiac RSK\/NHE-1 inhibition","volume":"174","author":"Chen","year":"2024","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.ejphar.2026.178561_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122184","article-title":"Vericiguat alleviates ventricular remodeling and arrhythmias in mouse models of myocardial infarction via CaMKII signaling","volume":"334","author":"Chen","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.178561_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116957","article-title":"A novel histone deacetylase inhibitor Se-SAHA attenuates isoproterenol-induced heart failure via antioxidative stress and autophagy inhibition","volume":"487","author":"Cheng","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178561_bib14","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s10741-024-10425-7","article-title":"Vericiguat in heart failure with reduced ejection fraction: hope or solid reality?","volume":"29","author":"Correale","year":"2024","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ejphar.2026.178561_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105077","article-title":"Synthesis and pharmacological evaluation of pomalidomide derivatives useful for sickle cell disease treatment","volume":"114","author":"de Melo","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejphar.2026.178561_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12933-025-02734-4","article-title":"Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets","volume":"24","author":"Delalat","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2026.178561_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173724","article-title":"PDE5 inhibition improves cardiac morphology and function in SHR by reducing NHE1 activity: repurposing Sildenafil for the treatment of hypertensive cardiac hypertrophy","volume":"891","author":"Escudero","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178561_bib18","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.bbamcr.2015.05.030","article-title":"Stress triggers mitochondrial biogenesis to preserve steroidogenesis in Leydig cells","volume":"1853","author":"Gak","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2026.178561_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/FJC.0000000000001625","article-title":"Canagliflozin mediates mitophagy through the AMPK\/PINK1\/Parkin pathway to alleviate ISO-induced cardiac remodeling","volume":"84","author":"Gong","year":"2024","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178561_bib20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1253\/circj.CJ-24-0659","article-title":"Soluble guanylate cyclase stimulator vericiguat attenuates Angiotensin II-Induced oxidative stress and cardiac remodeling","volume":"89","author":"Harada","year":"2025","journal-title":"Circ. J. : official journal of the Japanese Circulation Society"},{"key":"10.1016\/j.ejphar.2026.178561_bib21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/cvr\/cvae077","article-title":"Isthmin-1 alleviates cardiac ischaemia\/reperfusion injury through cGMP-PKG signalling pathway","volume":"120","author":"Hu","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.178561_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.117100","article-title":"Palmatine reverse aristolochic acid-induced heart failure through activating EGFR pathway via upregulating IKBKB","volume":"285","author":"Hu","year":"2024","journal-title":"Ecotoxicology and environmental safety"},{"key":"10.1016\/j.ejphar.2026.178561_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41467-023-44316-6","article-title":"TMEM55B links autophagy flux, lysosomal repair, and TFE3 activation in response to oxidative stress","volume":"15","author":"Jeong","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178561_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00345-024-04956-9","article-title":"Activation of the cGMP\/PKG\/ERK signaling pathway associated with PDE5Is inhibits fibroblast activation by downregulating autophagy in early progressive benign prostatic hyperplasia","volume":"42","author":"Jin","year":"2024","journal-title":"World J. Urol."},{"key":"10.1016\/j.ejphar.2026.178561_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41569-022-00756-z","article-title":"Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure","volume":"20","author":"Kamel","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178561_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111512","article-title":"Vericiguat enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction through microRNA-1180-3p\/ETS1 pathway","volume":"125","author":"Li","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2026.178561_bib27","article-title":"UHPLC-Q-Orbitrap HRMS and network analysis to explore the mechanisms of QiShenYiQi dripping pill for treating myocardial infarction","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178561_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/10742484231185252","article-title":"Vericiguat reduces electrical and structural remodeling in a rabbit model of atrial fibrillation","volume":"28","author":"Lou","year":"2023","journal-title":"J. Cardiovasc. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178561_bib29","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/s41467-022-29902-4","article-title":"CMYA5 establishes cardiac dyad architecture and positioning","volume":"13","author":"Lu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178561_bib30","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1111\/bph.15536","article-title":"cGMP and mitochondrial K(+) channels-compartmentalized but closely connected in cardioprotection","volume":"179","author":"Lukowski","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178561_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.freeradbiomed.2024.01.015","article-title":"Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress","volume":"213","author":"Luna-Marco","year":"2024","journal-title":"Free radical biology & medicine"},{"key":"10.1016\/j.ejphar.2026.178561_bib32","article-title":"Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-\u03baB signaling","volume":"165","author":"Ma","year":"2023","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.ejphar.2026.178561_bib33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fcvm.2019.00186","article-title":"SGLT2 inhibitors play a salutary role in heart failure via modulation of the mitochondrial function","volume":"6","author":"Maejima","year":"2019","journal-title":"Frontiers in cardiovascular medicine"},{"key":"10.1016\/j.ejphar.2026.178561_bib34","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/cvr\/cvab167","article-title":"CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensors","volume":"118","author":"Manfra","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.178561_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","article-title":"Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential","volume":"20","author":"Martin","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178561_bib36","article-title":"Differential sex-dependent susceptibility to diastolic dysfunction and arrhythmia in cardiomyocytes from obese diabetic HFpEF model","author":"Mira Hernandez","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.178561_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/fcp.12818","article-title":"Angiotensin receptor-neprilysin inhibitor (thiorphan\/irbesartan) improved cardiac function in a rat model of myocardial ischemic reperfusion injury","volume":"37","author":"Mohammed Abdulsalam","year":"2023","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178561_bib38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/CIRCRESAHA.119.315714","article-title":"PKG1\u03b1 Cysteine-42 Redox State controls mTORC1 activation in pathological cardiac hypertrophy","volume":"127","author":"Oeing","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.178561_bib39","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.122.061732","article-title":"Critical reanalysis of the mechanisms underlying the cardiorenal benefits of SGLT2 inhibitors and reaffirmation of the nutrient deprivation Signaling\/Autophagy Hypothesis","volume":"146","author":"Packer","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178561_bib40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/CIRCRESAHA.121.319582","article-title":"Endothelial cells induced progenitors into brown fat to reduce atherosclerosis","volume":"131","author":"Park","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.178561_bib41","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1021\/acsptsci.4c00240","article-title":"Sodium-Glucose cotransporter 2 (SGLT2) inhibitors: guardians against mitochondrial dysfunction and endoplasmic reticulum stress in heart diseases","volume":"7","author":"Pham","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejphar.2026.178561_bib42","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/ejhf.3076","article-title":"Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies","volume":"25","author":"Polovina","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2026.178561_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00018-023-04777-w","article-title":"Atrial natriuretic peptide stimulates autophagy\/mitophagy and improves mitochondrial function in chronic heart failure","volume":"80","author":"Raffa","year":"2023","journal-title":"Cell. Mol. Life Sci. : CMLS"},{"key":"10.1016\/j.ejphar.2026.178561_bib44","article-title":"Vericiguat global Study in participants with chronic heart failure: design of the VICTOR trial","author":"Reddy","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2026.178561_bib45","article-title":"Disruption of mitochondria-sarcoplasmic reticulum microdomain connectomics contributes to sinus node dysfunction in heart failure","volume":"119","author":"Ren","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejphar.2026.178561_bib46","doi-asserted-by":"crossref","first-page":"H1524","DOI":"10.1152\/ajpheart.00318.2024","article-title":"Early pathological mechanisms in a mouse model of heart failure with preserved ejection fraction","volume":"327","author":"Rosas","year":"2024","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2026.178561_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411497","article-title":"Regulation of mTOR signaling: emerging role of cyclic nucleotide-dependent protein kinases and implications for cardiometabolic disease","volume":"24","author":"Shi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178561_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010312","article-title":"Neprilysin inhibition in the prevention of anthracycline-induced cardiotoxicity","volume":"15","author":"Sobiborowicz-Sadowska","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2026.178561_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14054","article-title":"Heart failure in patients is associated with downregulation of mitochondrial quality control genes","volume":"53","author":"Svagusa","year":"2023","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2026.178561_bib50","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/ATVBAHA.119.312533","article-title":"Proinflammatory effect of endothelial microparticles is Mitochondria mediated and modulated through MAPKAPK2 (MAPK-Activated protein kinase 2) leading to attenuation of cardiac hypertrophy","volume":"39","author":"Tripathi","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.178561_bib51","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/cts.13677","article-title":"Vericiguat, a novel sGC stimulator: mechanism of action, clinical, and translational science","volume":"16","author":"Trujillo","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ejphar.2026.178561_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108185","article-title":"Recent advances in the pharmacological therapy of chronic heart failure: evidence and guidelines","volume":"238","author":"Tsutsui","year":"2022","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2026.178561_bib53","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.7150\/ijbs.101247","article-title":"The cGAS-STING\/PERK-eIF2\u03b1: individual or potentially collaborative signaling transduction in cardiovascular diseases","volume":"20","author":"Wan","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2026.178561_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.vph.2006.10.009","article-title":"Vasorelaxation induced by vascular endothelial growth factor in the human internal mammary artery and radial artery","volume":"46","author":"Wei","year":"2007","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178561_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072350","article-title":"Burn-Induced Cardiac mitochondrial dysfunction via interruption of the PDE5A-cGMP-PKG pathway","volume":"21","author":"Wen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178561_bib56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41420-023-01308-1","article-title":"HDAC1 disrupts the tricarboxylic acid (TCA) cycle through the deacetylation of Nur77 and promotes inflammation in ischemia-reperfusion mice","volume":"9","author":"Wu","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejphar.2026.178561_bib57","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1038\/s41418-020-0554-8","article-title":"The proteasome activator REG\u03b3 accelerates cardiac hypertrophy by declining PP2Ac\u03b1-SOD2 pathway","volume":"27","author":"Xie","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2026.178561_bib58","volume":"105","author":"Yan","year":"2025"},{"key":"10.1016\/j.ejphar.2026.178561_bib59","first-page":"12827","article-title":"MiR-449 improves cardiac function by regulating HDAC1 and cTnI","volume":"24","author":"Yang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2026.178561_bib60","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1096\/fj.201901951RR","article-title":"Potential contribution of ryanodine receptor 2 upregulation to cGMP\/PKG signaling-induced cone degeneration in cyclic nucleotide-gated channel deficiency","volume":"34","author":"Yang","year":"2020","journal-title":"FASEB J. : official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.ejphar.2026.178561_bib61","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1476-5381.2011.01308.x","article-title":"AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats","volume":"163","author":"Yang","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178561_bib62","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10557-021-07190-2","article-title":"Empagliflozin disrupts a Tnfrsf12a-Mediated feed forward loop that promotes left ventricular hypertrophy","volume":"36","author":"Yerra","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2026.178561_bib63","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.trsl.2024.07.005","article-title":"Vericiguat attenuates doxorubicin-induced cardiotoxicity through the PRKG1\/PINK1\/STING axis","volume":"273","author":"Zeng","year":"2024","journal-title":"Transl. Res. : J. Lab. Clin. Med."},{"key":"10.1016\/j.ejphar.2026.178561_bib64","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1536\/ihj.23-144","article-title":"B-Type natriuretic peptide inhibits the expression and function of SERCA2a in heart failure","volume":"65","author":"Zhai","year":"2024","journal-title":"Int. Heart J."},{"key":"10.1016\/j.ejphar.2026.178561_bib65","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.1038\/ncomms9665","article-title":"S-nitrosylation-dependent proteasomal degradation restrains Cdk5 activity to regulate hippocampal synaptic strength","volume":"6","author":"Zhang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178561_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117473","article-title":"Vericiguat as a novel PPAR\u03b1 ligand alleviates pressure-overload-induced heart failure","volume":"503","author":"Zhang","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178561_bib67","article-title":"Leucine-Rich repeat-containing G protein-coupled receptor 6 ameliorates pressure overload-induced cardiac hypertrophy by regulating Cardiomyocyte metabolic reprogramming","volume":"12","author":"Zhao","year":"2025","journal-title":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.ejphar.2026.178561_bib68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/1873-3468.14228","article-title":"The mitochondrial regulator PGC1\u03b1 is induced by cGMP-PKG signaling and mediates the protective effects of phosphodiesterase 5 inhibition in heart failure","volume":"596","author":"Zhu","year":"2022","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2026.178561_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0295566","article-title":"Vericiguat protects against cardiac damage in a pig model of ischemia\/reperfusion","volume":"18","author":"Zhu","year":"2023","journal-title":"PLoS One"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:34:27Z","timestamp":1777412067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":69,"alternative-id":["S0014299926000439"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178561","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vericiguat inhibits the progress of cardiac hypertrophy and prevents hypertrophy-induced heart failure by multiple mechanisms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178561"}}